Asbury (ABG) Q3 2025 earnings review
Acquisition Masks Organic Weakness; Long-Term TCA Growth Story Slashed
Asbury's Q3 headline results, showing a 13% revenue and 13% adjusted EPS growth, were entirely driven by the large Herb Chambers acquisition. The underlying organic business paints a weaker picture: while the high-margin Parts & Service segment remains a resilient growth engine (same-store gross profit +7%), it was not enough to offset declines in the core vehicle sales business, where same-store gross profit fell for both new (-4%) and used (-2%) vehicles. More concerningly, management dramatically lowered the long-term earnings outlook for its Total Care Auto (TCA) business, a key pillar of the bull thesis, citing a lower industry sales forecast. This suggests the path to future growth may be more challenging than previously anticipated.
🐂 Bull Case
The highly profitable Parts & Service business continues to be the bedrock of organic growth, with same-store gross profit increasing 7% YoY, driven by strong customer-pay demand.
Management demonstrated strong cost control, improving same-store adjusted SG&A as a percentage of gross profit by 32 basis points to 63.6% amidst an inflationary environment.
The Herb Chambers acquisition is already contributing positively, boosting the company's scale, luxury brand mix, and overall revenue and profit profile.
🐻 Bear Case
The long-term EPS contribution forecast from the TCA business for 2029 was slashed from $5.69 to just $0.81, a severe reduction that calls into question the ultimate value of this key initiative.
Same-store gross profits from vehicle sales are declining. New vehicle gross profit fell 4% and used vehicle gross profit fell 2%, indicating pressure on the core business.
Leverage increased to 3.2x following the Chambers acquisition. Management has prioritized deleveraging, which may limit capital available for share repurchases in the near term.
⚖️ Verdict: 🔴
Bearish. The strong headline numbers are misleading as they are entirely propped up by a large acquisition. The organic business is showing signs of weakness in its largest segments (vehicle sales). The drastic downward revision to the TCA outlook is a significant blow to the long-term growth narrative and highlights extreme sensitivity to macro forecasts. While Parts & Service is a bright spot, it's not enough to outweigh the core business pressures and the diminished long-term thesis.
Key Themes
Long-Term TCA Promise Fades as Guidance is Slashed
A major red flag emerged as management dramatically revised the long-term outlook for its Total Care Auto (TCA) service contract business. The projected 2029 incremental EPS contribution was cut from $5.69 to just $0.81. This 86% reduction was attributed to a relatively modest change in the long-term industry sales (SAAR) forecast from 17 million units to the high-15 to low-16 million range. This extreme sensitivity calls into question the reliability of the model and significantly dampens a key pillar of the long-term investment thesis. The path to $5+ of EPS from this initiative has been pushed out to 2031 or later.
M&A Masks Faltering Same-Store Vehicle Profits
While the Herb Chambers acquisition boosted total company results, the organic business is struggling. On a same-store basis, new vehicle gross profit declined 4% YoY, and used vehicle gross profit fell 2% on 4% lower unit volume. Management explicitly noted that used vehicle performance is their 'biggest opportunity to improve execution,' signaling internal recognition of the weakness in this core segment.
Parts & Service Remains the Resilient Growth Engine
The high-margin Parts & Service business continues to be the company's most reliable organic performer. Same-store gross profit grew 7% YoY, driven by an 8% increase in the crucial customer-pay segment. Gross margin expanded by 172 basis points to 58.8%. With an aging vehicle fleet and increasing vehicle complexity, this segment provides a stable and profitable foundation for the company, helping to offset cyclicality in vehicle sales.
Leverage Spikes Post-Chambers Deal
Following the completion of the large Herb Chambers acquisition, the company's transaction-adjusted net leverage ratio rose to 3.2x. Management stated that deleveraging the balance sheet is a primary focus for the next 12 months. This necessary focus on debt reduction may limit the capital available for opportunistic share repurchases, even as the company resumed buybacks with a $50 million purchase in the quarter.
Tekion Rollout Continues, but Full Benefits Remain Distant
The strategic transition to the Tekion dealership management system (DMS) is ongoing, with 23 stores now converted. However, management noted that the learning curve for experienced employees is longer than anticipated, taking 6-7 months to reach efficiency versus an expected 3 months. While the long-term goals of lower software costs and higher employee productivity remain, full SG&A savings are not expected to be realized until late 2026 or early 2027.
Other KPIs
Decelerating. This represents a 10% decline from $3,552 in the prior year quarter. The result is trending towards management's long-term normalized range of $2,500 to $3,000, indicating that the period of unusually high vehicle margins continues to fade.
Year-to-date free cash flow increased by $50 million compared to the same period in 2024. The company's ability to generate cash remains strong, providing the resources to fund capital expenditures, pay down debt from the Chambers acquisition, and return capital to shareholders via buybacks.
Guidance
Decelerating. Management reiterated their expectation that new vehicle gross profit per unit will continue to decline from the current $3,188 level to a more normalized long-term range. The timing remains uncertain and sensitive to macro conditions.
Management revised their full-year CapEx forecast down from a prior estimate of ~$250 million. This reduction will help preserve cash for deleveraging priorities.
The company provided an estimated adjusted effective tax rate for the upcoming quarter, in line with the Q3 rate of 25.4%.
Key Questions
TCA Model Sensitivity
The revised TCA outlook implies extreme sensitivity to SAAR assumptions. What gives you confidence in the new, lower forecast, and what other key variables could cause another significant revision in the future?
Used Vehicle Turnaround Strategy
Management called Used Vehicles the 'biggest opportunity for improvement.' Besides waiting for market supply to recover in 2026, what specific, actionable steps are being taken in the next 1-2 quarters to reverse the negative trends in same-store unit volume and gross profit?
Tekion Adoption Curve
You mentioned it takes legacy employees 6-7 months to become efficient on Tekion, longer than expected. How does this extended learning curve impact the timeline for realizing SG&A savings, and are you implementing any new training programs to accelerate this adoption?